PYXS 8-K: SEC filing
Filed with the SEC on · accession 0001193125-26-460698
PYXS filed a 8-K (current report) with the SEC on Nov 13, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -1.6% by the first close after the filing.
Summary of the filing
Pyxis Oncology stockholders approved an increase in authorized common shares from 190,000,000 to 380,000,000 at a special meeting, and the company filed the charter amendment effective November 13, 2026.
Key details
How PYXS stock reacted
Close before
$1.58
Nov 12, 2026
First close after
-1.58%
$1.55
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for PYXS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PYXS?
Click hereFrequently asked questions
What did PYXS file with the SEC on Nov 13, 2026?
PYXS filed a 8-K (SEC filing). Pyxis Oncology stockholders approved an increase in authorized common shares from 190,000,000 to 380,000,000 at a special meeting, and the company filed the charter amendment effective November 13, 2026.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did PYXS stock react to this filing?
PYXS closed at $1.58 before the filing and $1.55 on Nov 13, 2026 (-1.58%).
Other PYXS SEC filings
- 8-K · SEC filingNov 5, 2026
- 10-Q · SEC filingNov 5, 2026
- SCHEDULE 13G/A · SEC filingNov 3, 2026
- DEF 14A · SEC filingOct 21, 2026
- SCHEDULE 13G/A · SEC filingOct 9, 2026
- SCHEDULE 13G · SEC filingOct 5, 2026
- SCHEDULE 13G/A · SEC filingOct 2, 2026
- 424B5 · Secondary offeringOct 1, 2026
- 8-K · Secondary offeringOct 1, 2026
- 8-K · Fda approvalSep 9, 2026
Get alerts when PYXS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days